California Public Employees Retirement System Next Cure, Inc. Transaction History

California Public Employees Retirement System

  • $141 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$7.6 - $10.28 $253,080 - $342,324
-33,300 Closed
0 $0
Q4 2020

Feb 02, 2021
SELL
$9.47 - $12.43 $29,603 - $38,856
-3,126 Reduced 8.58%
33,300 $363,000
Q2 2020

Aug 12, 2020
BUY
$21.19 - $40.2 $129,767 - $246,184
6,124 Added 20.21%
36,426 $781,000
Q1 2020

May 12, 2020
BUY
$32.32 - $58.37 $824,160 - $1.49 Million
25,500 Added 531.03%
30,302 $1.12 Million
Q4 2019

Jan 27, 2020
BUY
$25.0 - $92.22 $120,050 - $442,840
4,802 New
4,802 $270,000

Others Institutions Holding NXTC

# of Institutions
42
Shares Held
15.9M
Call Options Held
0
Put Options Held
0
View Full List

About NextCure, Inc.

NXTC Quotes by TradingView
  • Ticker NXTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,748,800
  • Market Cap $22.5M
  • Description
  • NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...
More about NXTC
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email